Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.60USD
14 Jun 2019
Change (% chg)

$-0.10 (-2.70%)
Prev Close
$3.70
Open
$3.68
Day's High
$3.69
Day's Low
$3.52
Volume
44,845
Avg. Vol
79,770
52-wk High
$14.52
52-wk Low
$3.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -0.044
FY 2018 Dec '18 1.48 -0.058
Sep '18 40.79 0.008
Jun '18 9.04 -0.078
Mar '18 8.20 -0.037
FY 2017 Dec '17 4.27 -0.049
Sep '17 27.18 -0.002
Jun '17 3.52 -0.036
Mar '17 2.86 -0.051
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 7 2.00 7.00 0.00 0.00
Quarter Ending Sep-19 7 2.00 7.00 0.00 0.00
Year Ending Dec-19 7 8.86 21.00 0.00 25.50
Year Ending Dec-20 7 14.43 36.00 0.00 18.00
Earnings (per share)
Quarter Ending Jun-19 5 -0.33 -0.29 -0.40 -0.32
Quarter Ending Sep-19 5 -0.31 -0.28 -0.35 -0.31
Year Ending Dec-19 5 -1.14 -0.94 -1.34 -1.21
Year Ending Dec-20 5 -1.09 -0.83 -1.45 -1.41
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta -- 1.08 0.87
Price to Sales (TTM) 44.03 49.50 8.43
Price to Book (MRQ) 3.33 10.13 5.27
Price to Tangible Book (MRQ) 3.35 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions 62.37 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 973.48 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago 48.46 49.05 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 30.20 75.32 48.21
EPS (TTM) vs TTM 1 Yr. Ago -44.84 -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 7.86 3.57 2.98
LT Debt to Equity (MRQ) 0.00 18.62 11.35
Total Debt to Equity (MRQ) 0.00 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.27 52.39
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -435.08 -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -457.44 -184.93 5.67
Operating Margin - 5 Yr. Avg. -- -127.41 8.00
Pre-Tax Margin (TTM) -432.60 -175.62 4.69
Pre-Tax Margin - 5 Yr. Avg. -- -133.20 8.28
Net Profit Margin (TTM) -438.00 -182.34 1.42
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 58,154 7,653,013 819,596,351
Net Income/Employee (TTM) -254,715 513,435 92,773,650
Receivable Turnover (TTM) 24.65 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) 0.07 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -28.98 6.37 10.65
Return on Assets - 5 Yr. Avg. -- 5.47 11.77
Return on Investment (TTM) -32.06 8.90 13.82
Return on Investment - 5 Yr. Avg. -- 6.78 15.32
Return on Equity (TTM) -35.60 10.04 15.24
Return on Equity - 5 Yr. Avg. -- 8.36 16.41
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adaptimmune Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.62 -11.77 36 99
13 Week 66.87 58.74 99 95
26 Week 43.16 32.28 99 97
52 Week 20.18 1.86 99 70
YTD 101.48 76.94 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 73.29%
# of Holders: 79
Total Shares Held: 76,749,149
3 Mo. Net Change: 80,098
# New Positions: 8
# Closed Positions: 23
# Increased Positions: 29
# Reduced Positions: 40
# Net Buyers: -11
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.